We’ll get a wealth of heavyweight earnings this week, plus US, UK and eurozone rate decisions, the US nonfarm payrolls and German and eurozone inflation data. The packed schedule of updates includes ExxonMobil, Pfizer, Amgen, McDonald’s, UPS, Phillips 66, Caterpillar, AMD, Mondelez, Meta, GSK, T-Mobile, Vodafone, Apple, Alphabet, Amazon, Shell, Eli Lilly, Merck, ConocoPhillips, Honeywell, Starbucks, Ford, Deutsche Bank and Sanofi.

Monday 30 January

A busy week begins with earnings from Dutch semiconductor firm NXP, financial services groups Principal and Franklin Resources and home appliance maker Whirlpool. We’ll also get the first estimate of German GDP for the fourth quarter and, late in the day, the Japanese jobs/application ratio, industrial production and retail sales.

Stay ahead of market-moving events with our economic calendar.

Tuesday 31 January

Oil supermajor ExxonMobil, currently suing the EU to prevent its windfall tax on oil firms, reports to the market on Tuesday. Other companies posting figures include pharma firms Pfizer and Amgen, fast food giant McDonald’s, delivery service UPS, energy firm Phillips 66, construction equipment manufacturer Caterpillar, semiconductor maker AMD, food brand owner Mondelez, petrol refiner Marathon Petroleum, US automaker General Motors, food service supplier Sysco and video game firm Electronic Arts. Also look out for Australian retail sales, China’s NBS manufacturing and non-manufacturing PMI data, French GDP, German retail sales and CPI and, in the US, the Conference Board’s consumer confidence and the latest Chicago PMI.

Buy or sell oil and other commodities with Intertrader.

Wednesday 1 February

Facebook parent Meta posts earnings on Wednesday, after reports emerged last week of a deal with BuzzFeed to provide AI-generated content. We’ll also get updates from lab tech supplier Thermo Fisher Scientific, pharma firms GSK and Novartis, wireless network operators T-Mobile and Vodafone, tobacco group Altria, medical device maker Boston Scientific, US health insurer Humana, waste management firm WM, insurance group MetLife, pharma distributors McKesson and AmerisourceBergen and fire safety multinational Johnson Controls. As well as manufacturing PMI data for Australia (late on Tuesday), Japan, China, France, Germany, the eurozone, the UK and the US, we’ll have eurozone CPI and the US JOLTs labour market report. The Fed will also announce its latest decision on US interest rates at 7pm (UK time).

Take a broad market view with our stock index contracts.

Thursday 2 February

Thursday is packed with updates from tech giant Apple, Google parent Alphabet, e-commerce heavyweight Amazon, oil supermajor Shell, pharma firms Eli Lilly, Merck and Bristol-Myers Squibb, oil explorer ConocoPhillips, wireless tech firm Qualcomm, Dow component Honeywell, coffee chain Starbucks, carmaker Ford, cosmetics group Estée Lauder, electrical equipment manufacturer ABB and DAX component Deutsche Bank. Both the Bank of England and the ECB will be announcing monetary policy decisions, with both central banks expected to raise interest rates by 50 basis points. We’ll also see the latest Australian building approvals, German trade balance, US Q4 nonfarm productivity and December factory orders.

Go long or short on a wide range of global equities.

Friday 3 February

Friday’s highlight is the US nonfarm payrolls and unemployment rate, due at 1.30pm (UK time). In December the US economy added 223,000 jobs, ahead of expectations. Keep an eye out too for services PMI data for Australia (late on Thursday), Japan, China, France, Germany, the eurozone, the UK and the US, plus the ISM’s US non-manufacturing PMI. Earnings come from French pharma firm Sanofi, health insurance group Cigna, financial services multinational Aon, US biotech firm Regeneron, chemical company LyondellBasell and education group Adtalem.

Published: 30 January 2023

You should under no circumstances consider the information and comments provided as an offer or solicitation to invest. This is a macro summary of scheduled news announcements and is not investment advice, independent research or an investment recommendation. The information provided is believed to be accurate at the date the information is produced.